Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT03070899 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids
Heavy Menstrual Bleeding

Interventions

DRUG: OBE2109
DRUG: Placebo to match OBE2109
DRUG: Placebo to match Add-back
DRUG: Add-back

Sponsor

ObsEva SA